Literature DB >> 26662391

DNA repair gene XRCC3 T241M polymorphism and susceptibility to hepatocellular carcinoma in a Chinese population: a meta-analysis.

R B Ji1, Y S Qian1, A R Hu2, Y R Hu1.   

Abstract

Numerous studies have evaluated the association between the X-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3) T241M polymorphism and hepatocellular carcinoma (HCC) risk. However, the results of such investigations have proved inconsistent. Therefore, we performed a meta-analysis of the association between this polymorphism and HCC risk in the Chinese population. Published literature from PubMed and China National Knowledge Infrastructure databases was retrieved, and a total of 5 case-control studies consisting of 2967 patients and 3874 controls were included in this meta-analysis, which revealed a significant association between the XRCC3 T241M polymorphism and HCC risk (TT vs MM: OR = 6.54, 95%CI = 2.14-19.99; TT vs MT: OR = 4.72, 95%CI = 2.26-9.86; dominant model: OR = 0.38, 95%CI = 0.26-0.57; recessive model: OR = 1.27, 95%CI = 0.99-1.62). In a subgroup analysis by sample size (number of subjects > 1000), similar results were obtained. Thus, XRCC3 T241M polymorphism may constitute a risk factor for HCC in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26662391     DOI: 10.4238/2015.December.7.11

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  2 in total

1.  Genetic biomarkers for hepatocellular cancer risk in a caucasian population.

Authors:  Elena De Mattia; Erika Cecchin; Jerry Polesel; Alessia Bignucolo; Rossana Roncato; Francesco Lupo; Marina Crovatto; Angela Buonadonna; Claudio Tiribelli; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

2.  Genome Profiling for Aflatoxin B1 Resistance in Saccharomyces cerevisiae Reveals a Role for the CSM2/SHU Complex in Tolerance of Aflatoxin B1-Associated DNA Damage.

Authors:  Nick St John; Julian Freedland; Henri Baldino; Francis Doyle; Cinzia Cera; Thomas Begley; Michael Fasullo
Journal:  G3 (Bethesda)       Date:  2020-11-05       Impact factor: 3.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.